Completed NA INTERVENTIONAL 2-arm NCT07252193

Generative AI-Based Simulation for Diagnostic Communication in Type 2 Diabetes (DIALOGUE-DM2) (DIALOGUE-DM2)

Generative AI Simulation for Diagnostic Communication in Type 2 Diabetes: A Randomized Controlled Trial (DIALOGUE-DM2)

Sponsor: Universidad Nacional Autonoma de Mexico

Conditions Artificial Intelligence Simulation Diagnostic Communication Medical Education Type 2 Diabetes Mellitus

Interventions AI-Based Simulation Training (DIALOGUE-DM2) Traditional Training

Updated 2 times since 2025 Last updated: Dec 26, 2025 Started: Sep 22, 2025 Primary completion: Dec 18, 2025 Completion: Dec 20, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07252193, this NA trial focuses on Artificial Intelligence Simulation and Diagnostic Communication and remains completed. Sponsored by Universidad Nacional Autonoma de Mexico, it has been updated 2 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Jan 2026 — Present [monthly]

Completed NA

Status: Active Not Recruiting → Completed
Dec 2025 — Jan 2026 [monthly]

Active Not Recruiting NA

First recorded

Sep 2025

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Universidad Nacional Autonoma de Mexico

Data source: Universidad Nacional Autonoma de Mexico

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tlalnepantla, Mexico